Cold-Induced Urticaria: GTX-B001 Treatment

We are testing a new treatment for people with cold-induced urticaria to see how well it is tolerated and its effects on symptoms. The study includes both healthy volunteers and patients.

1-2 yearsSafety phase (I)AllergologyDermatology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Charite Research Organisation GmbH
Charite Research Organisation
Berlin, Germany
Fraunhofer Institute For Translational Medicine And Pharmacology ITMP
Instituit für Translationale Medizin und Pharmakologie ITMP
Teltow, Germany
Sponsor: Granular Therapeutics Limited
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.